MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.200
-0.090 (-3.93%)
At close: Nov 13, 2026, 4:00 PM EST
2.220
+0.020 (0.91%)
After-hours: Nov 13, 2026, 7:30 PM EST
MacroGenics Employees
MacroGenics had 293 employees as of December 31, 2025. The number of employees decreased by 48 or 14.08% compared to the previous year. That makes MacroGenics the 24,045th largest employer in the world and 3,081st in the United States.
Employees
293
Change (1Y)
-48
Growth (1Y)
-14.08%
Revenue / Employee
$480,563
Profits / Employee
-$175,734
Market Cap
140.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | -48 | -14.08% |
| Dec 31, 2024 | 341 | 2 | 0.59% |
| Dec 31, 2023 | 339 | -18 | -5.04% |
| Dec 31, 2022 | 357 | -70 | -16.39% |
| Dec 31, 2021 | 427 | 57 | 15.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Upstream Bio | 75 |
| Armata Pharmaceuticals | 61 |
| Sionna Therapeutics | 59 |
| ALX Oncology Holdings | 48 |
| LENZ Therapeutics | 40 |
| Compass Therapeutics | 39 |
| Jyong Biotech | 27 |
MGNX News
- 2 days ago - MacroGenics reports Q3 EPS (32c), consensus (13c) - TheFly
- 2 days ago - MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress - GlobeNewsWire
- 3 days ago - MacroGenics Quarterly report: Q3 2026 - Filings
- 3 days ago - MacroGenics Earnings release: Q3 2026 - Filings
- 4 days ago - MacroGenics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 9 days ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 11 days ago - MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D. - GlobeNewsWire
- 20 days ago - MacroGenics announces interim data from LINNET study evaluating lorigerlimab - TheFly